Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foxx Medical Chile
Santiago, Región Metropolitana, Chile
- Ownership
- Private
- Development stage
- Other
01
Overview
Foxx Medical Chile began Chilean introduction of CytoSorb in 2016. Early experience reported successful ICU recoveries in critically ill patients unresponsive to standard protocol, facilitating recovery from severe sepsis and SIRS. No proprietary pipeline or clinical trial results reported.
- Therapeutic areas
- CardiovascularImmunologyInfectious DiseasesOther
- Modalities
- Deviceextracorporeal therapy
- Industry
- Therapeutic Medical Devices
02
Partnerships
CytoSorbents Corporation (exclusive Chile distributor for CytoSorb)
Beyond the preview
Go deeper on Foxx Medical Chile.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Foxx Medical Chile.